CITIC Construction Investment has observed that the overseas investment and financing landscape experiences quarterly fluctuations, with the demand for CXO services diversifying according to various stages and disease areas. Meanwhile, domestic investment and financing activities are thriving, displaying robust resilience. Consequently, the growth potential of the CXO sector remains highly promising. Although the short-term impact of AI on the pharmaceutical and pharmaceutical outsourcing industries is relatively constrained, the market has generally come to a consensus that new technologies will, in the long run, revolutionize the industry's development trajectory. This transformation will yield differentiated effects in the early research and development phase (CRO) and confer overall advantages in the production phase (D, M).
